Metis TechBio, a biotech company using AI to deliver and formulate drugs, surged as much as 185% in its Hong Kong market debut after raising ~$270M in its IPO (Amber Tong/Bloomberg)

Amber Tong / Bloomberg: Metis TechBio, a biotech company using AI to deliver and formulate drugs, surged as much as 185% in its Hong Kong market debut after raising ~$270M in its IPO — Shares of Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs …